{
    "clinical_study": {
        "@rank": "60412", 
        "arm_group": {
            "arm_group_label": "Sterile Humidification Device, MyPurMist", 
            "arm_group_type": "Experimental", 
            "description": "Sterile Humidification Device Twice a day, 15 minutes each 12 weeks"
        }, 
        "brief_summary": {
            "textblock": "This is a single arm study of the use of a personalized sterile humidification device for 12\n      weeks for head and neck cancer patients undergoing radiation therapy to determine if the\n      usage of this humidification system will result in a decrease in severity in head and neck\n      related quality of life as measured by the MDASI HN subscale following radiation therapy as\n      compared with historical experience. In addition, we are exploring correlative measures\n      using CRP, IL-1, IL-6, and TNF-alpha level measurements as these are directly related to\n      mucositis and presumably related to quality of life as indicated by the patient."
        }, 
        "brief_title": "Study of Personalized Sterile Humidification Device for Mucositis in Head and Neck Cancer Patients", 
        "completion_date": {
            "#text": "July 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Head and Neck Cancer", 
        "condition_browse": {
            "mesh_term": [
                "Head and Neck Neoplasms", 
                "Mucositis"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Receiving a dose of radiation therapy greater than or equal to 6000 cGy to one third\n             of the oral cavity.\n\n          -  Receiving definitive or post-operative adjuvant radiotherapy.\n\n          -  Receiving radiotherapy or chemoradiation.\n\n          -  Of age greater than 18 years.\n\n          -  Life expectancy greater than 6 months.\n\n          -  Able to provide informed consent.\n\n          -  Participation of patients on other clinical trial protocols permitted, if not\n             prohibited by trial guidelines.\n\n        Exclusion Criteria:\n\n          -  Undergoing induction or neoadjuvant chemotherapy prior to radiotherapy.\n\n          -  Treatment with amifostine or palifermin (keratinocyte growth factor) during\n             radiotherapy.\n\n          -  High risk for poor compliance with radiotherapy, humidification, or follow-up as\n             assessed by the investigator."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 20, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01930435", 
            "org_study_id": "CC# 13202"
        }, 
        "intervention": {
            "arm_group_label": "Sterile Humidification Device, MyPurMist", 
            "intervention_name": "Sterile Humidification Device", 
            "intervention_type": "Device", 
            "other_name": "MyPurMist"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": "Quality of Life", 
        "lastchanged_date": "April 10, 2014", 
        "location": {
            "contact": {
                "email": "yoms@radonc.ucsf.edu", 
                "last_name": "Sue Yom, M.D.", 
                "phone": "415-353-9893"
            }, 
            "facility": {
                "address": {
                    "city": "San Francisco", 
                    "country": "United States", 
                    "state": "California", 
                    "zip": "94115"
                }, 
                "name": "Helen Diller Family Comprehensive Center, UCSF"
            }, 
            "investigator": {
                "last_name": "Sue Yom, M.D.", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "A Phase II Study Monitoring Quality of Life and Correlative Biomarkers of Mucositis in Head and Neck Cancer Patients Undergoing Radiation Therapy Utilizing a Personalized Sterile Humidification Device", 
        "other_outcome": [
            {
                "measure": "Change from baseline in salivary inflammatory biomarkers (CRP, IL-1, IL-6, TNF-alpha) after use of the personalized sterile humidification system.", 
                "safety_issue": "No", 
                "time_frame": "6 weeks"
            }, 
            {
                "measure": "Relationship between the change from baseline in salivary inflammatory biomarkers and the change from baseline in the overall MDASI-HN score after use of the personalized sterile humidification system.", 
                "safety_issue": "No", 
                "time_frame": "6 weeks"
            }, 
            {
                "measure": "Relationship between the change from baseline in salivary inflammatory biomarkers and the change from baseline in the MDASI-HN subscale score after use of the personalized sterile humidification system.", 
                "safety_issue": "No", 
                "time_frame": "6 weeks"
            }, 
            {
                "measure": "Relationship between the change from baseline in salivary inflammatory biomarkers after use of the personalized sterile humidification system and the clinician graded CTCAE-rated mucositis score.", 
                "safety_issue": "No", 
                "time_frame": "6 weeks"
            }, 
            {
                "measure": "Change from baseline in salivary inflammatory biomarkers (CRP, IL-1, IL-6, TNF-alpha) after use of the personalized sterile humidification system.", 
                "safety_issue": "No", 
                "time_frame": "12 weeks"
            }, 
            {
                "measure": "Relationship between the change from baseline in salivary inflammatory biomarkers and the change from baseline in the overall MDASI-HN score after use of the personalized sterile humidification system.", 
                "safety_issue": "No", 
                "time_frame": "12 weeks"
            }, 
            {
                "measure": "Relationship between the change from baseline in salivary inflammatory biomarkers and the change from baseline in the MDASI-HN subscale score after use of the personalized sterile humidification system.", 
                "safety_issue": "No", 
                "time_frame": "12 weeks"
            }, 
            {
                "measure": "Relationship between the change from baseline in salivary inflammatory biomarkers after use of the personalized sterile humidification system and the clinician graded CTCAE-rated mucositis score.", 
                "safety_issue": "No", 
                "time_frame": "12 weeks"
            }
        ], 
        "overall_contact": {
            "email": "HutchinsonR@cc.ucsf.edu", 
            "last_name": "Romobia Hutchinson", 
            "phone": "415-353-4294"
        }, 
        "overall_official": {
            "affiliation": "University of California, San Francisco", 
            "last_name": "Sue Yom, M.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "April 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Decreased severity in quality of life as measured by the subscale MDASI-HN score.", 
            "safety_issue": "No", 
            "time_frame": "6 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01930435"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Decreased severity in quality of life as measured by the overall MDASI-HN score.", 
                "safety_issue": "No", 
                "time_frame": "6 weeks"
            }, 
            {
                "measure": "Relationship between the MDASI-HN subscale score with the clinician graded CTCAE-rated mucositis score.", 
                "safety_issue": "No", 
                "time_frame": "12 weeks"
            }, 
            {
                "measure": "Relationship between the overall MDASI-HN score with the clinician graded CTCAE-rated mucositis score.", 
                "safety_issue": "No", 
                "time_frame": "6 weeks"
            }, 
            {
                "measure": "Rate of feeding tube placement in patients who use personalized sterile humidification.", 
                "safety_issue": "No", 
                "time_frame": "12 weeks"
            }, 
            {
                "measure": "Rate of hospitalization in patients who use personalized sterile humidification.", 
                "safety_issue": "No", 
                "time_frame": "12 weeks"
            }, 
            {
                "measure": "Level of compliance with use of personalized sterile humidification.", 
                "safety_issue": "No", 
                "time_frame": "Anticipated of 2 years"
            }, 
            {
                "measure": "Relationship between the overall MDASI-HN score with the clinician graded CTCAE-rated mucositis score.", 
                "safety_issue": "No", 
                "time_frame": "12 weeks"
            }
        ], 
        "source": "University of California, San Francisco", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of California, San Francisco", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2013", 
        "study_design": "Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}